BNET Industries
Market Cap:$270.1M
Last Fiscal Year Sales:$47.1M
- Public
- US
Dow Jones Description
We are a genetics company committed to providing genetic analysis products, services and diagnostic applications. Our products and services are designed to translate the results of genomic research into solutions for biomedical research, translational research, molecular medicine applications and research conducted in the agro (agricultural and livestock) industry. Our development efforts in various diagnostic applications include areas of noninvasive diagnostics in prenatal, oncology and infectious diseases and other disorders. Our proprietary MassARRAY system, comprised of hardware, software applications, consumable chips and reagents, is a high performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. Our MassARRAY research and development efforts are committed to producing new and improved components and applications that deliver greater system versatility and reduce the cost per data point generated. MassARRAY technology is widely accepted as a leading high-performance DNA analysis platform for the fine mapping genotyping and quantitative gene expression markets and is gaining traction in new developing markets, such as epigenomics and pathogen typing. Our customers include some of the worldwide premier clinical research laboratories, biotechnology companies and academic institutions, as well as various government agencies. ...
Number of Employees 248
Contact Information
3595 John Hopkins Ct
San Diego, California 92121-1331
(858) 202-9000
Peer Companies
NAICS Code : 541710
Recent Events
-
PicksThatMove.com Announces Investment Opinion on Sequenom Inc., Gabriel Resources Ltd., Rentech Inc., Imaging 3 Inc.,...
-
Sequenom Q3 Loss Widens - Update
-
Sequenom faces fraud suit from Xenomics
-
Sequenom, Ibis settle lawsuit
-
Sequenom names Maier as interim CFO
-
ATVI, RMBS, MRVL, SQNM, ERIC, AKAM With Highest Daily Short Volume On
-
Sequenom discloses probes following firings
-
Sequenom ousts CEO, other execs
-
Sequenom tumbles after execs fired amid test woes
-
Investors Remain Hopeful About Sequenom's Prospects
-
Sequenom Ousts CEO After Finding Errors, Inconsistencies In Down Syndrome Test; CFO Resigns
News & Analysis
Filter by
healthcare and sequenom inc. - All News and Analysis
Spectrum Pharmaceuticals, Sequenom Shares Rise on Heavy Volume
Seeking Alpha
- 2009-09-01
Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) jumped on twice the average volume Monday. Shares for the biopharmaceutical company, which focuses on pioneering novel cancer therapies with a focus primarily in the areas of hematology-oncology and urology, are under a heavy accumulation which is related to Spectrum’s dealings with the FDA,...
Exact Sciences Plays Hard to Get with Sequenom
Seeking Alpha
- 2009-01-14
Trader Mark submits: I've asked mother market to drop Sequenom SQNM to $21 so I can reload the position - a bevy of limit orders waiting. Missed it by THAT much....Remember this will be a news event driven stock - end of January test results will cause a quite...
China Medical Embraces Molecular Diagnostics
Seeking Alpha
- 2008-12-25
Mike Havrilla submits: China Medical CMED offers a compelling value since losing about 60% of its market value in the past year, with shares trading very close to August 2005 IPO levels at the close yesterday of under 18 bucks click on chart to enlarge. CMED is also included in...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Newspapers Will Survive Only If They Remember Why They Exist 6 votes
Presented by American Express